ext_210135 ([identity profile] pandemonium-213.livejournal.com) wrote in [personal profile] huinare 2014-06-25 05:01 pm (UTC)

Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β-1a) in Patients with Relapsing-Remitting Multiple Sclerosis

Not yet posted. In progress. Plenty of Doom and Gloom (for me).
(44 comments)

Post a comment in response:

This account has disabled anonymous posting.
If you don't have an account you can create one now.
HTML doesn't work in the subject.
More info about formatting
 
Notice: This account is set to log the IP addresses of everyone who comments.
Links will be displayed as unclickable URLs to help prevent spam.